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Macrophages play a central role in tuberculosis, as the site of primary infection,
inducers and effectors of inflammation, innate and adaptive immunity, as well as
mediators of tissue destruction and repair. Early descriptions by pathologists have
emphasized their morphological heterogeneity in granulomas, followed by delineation
of T lymphocyte-dependent activation of anti-mycobacterial resistance. More recently,
powerful genetic and molecular tools have become available to describe macrophage
cellular properties and their role in host-pathogen interactions. In this review we discuss
aspects of macrophage heterogeneity relevant to the pathogenesis of tuberculosis and,
conversely, lessons that can be learnt from mycobacterial infection, with regard to the
immunobiological functions of macrophages in homeostasis and disease.
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INTRODUCTION
Tuberculosis (TB), caused by the bacterial pathogen Mycobacterium tuberculosis (MTB), is an
airborne infection that primarily affects the lungs, and remains a major global health problem
responsible for 1.5 million deaths annually (WHO)1. Upon inhalation, MTB organisms seed the
alveolar space in the lung, where they are captured by alveolar macrophages. This is followed
by an early inflammatory response, induced by both bacterial and host factors, which results in
recruitment of leukocytes from neighboring blood vessels to the site of infection. These include
monocytes which differentiate into various populations of tissue macrophages, such as epithelioid
cells, foamy macrophages and multinucleated Langhans giant cells, to create macrophage-rich
granulomatous lesions (Taylor et al., 2006; Volkman et al., 2010). Initially, granulomas are cellular
aggregates of the different macrophages and other innate immune cells surrounded by fibroblasts
(Ulrichs et al., 2004; Ehlers and Schaible, 2012; Guirado and Schlesinger, 2013). With the onset
of adaptive immunity, granulomas acquire a more solid, intact structure with a lymphocytic cuff
composed of T and B cells at their periphery. Later in infection, granulomas can undergo complex
remodeling. For reasons not yet fully understood, the solid granuloma can accumulate necrotic
damage that results in the formation of caseum at the center. Necrotic granulomas may undergo
1WHO. World Health Organization Tuberculosis Fact sheet. http://www.who.int/mediacentre/factsheets/fs104/en/index.
html. In, (January 2018).
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liquefaction to form cavitary lesions, giving the bacteria access to
nearby airways and thus the ability to spread (Russell et al., 2010)
within the lung and elsewhere within the body.
Granulomas have been assigned wide-ranging functions, some
of which also depend on the animal model studied. In zebrafish,
for example, granulomas have been depicted as vehicles that
help spread the pathogen to other sites within the organism
(Ramakrishnan, 2012). Different investigators have described
granulomas as a successful method of sequestering a chronic
pathogen (Saunders and Cooper, 2000; Nathan, 2016). However,
if containment fails, granulomas may simply become structures
that provide nutrients and a niche for the bacteria to replicate
without immune restriction (Peyron et al., 2008).
Macrophages are the predominant host cells implicated in
entry, growth and restriction within the infected host. Both
MTB and macrophages are heterogeneous in metabolic activity
and their interaction determines the outcome of infection.
Before considering various aspects of the host-pathogen
response to infection, we summarize present understanding
of the heterogeneous origin, differentiation and activation of
monocytes and tissue macrophages, the dispersed organ known
as the Mononuclear Phagocyte System (MPS).
HETEROGENEITY OF MACROPHAGES
AND PATHOGENS
There has been a paradigm shift in our understanding of
the origin, differentiation, distribution and properties of the
cells of the MPS (Ginhoux and Guilliams, 2016; Gordon and
Plüddemann, 2017). Almost all current knowledge is based on
studies in the mouse, and, although not identical in detail,
the broad outlines are likely to be similar in the human.
The main shift in our thinking arises from discovery of the
mixed origins of mouse macrophages from yolk sac and fetal
liver precursors during development, and postnatally from bone
marrow. Embryo-derived “monocytes” and macrophages seed
tissue resident macrophages throughout the body, turning over
slowly at local sites where they persist throughout adult life.
As required, e.g., in the gut (Bujko et al., 2018), tissue-resident
macrophages are replenished from bone marrow hematopoietic
stem cells (HSC), to a variable extent in different organs.
Abbreviations: Adam-17, disintegrin and metalloproteinase17; ADCC, antibody-
dependent cellular cytotoxicity, ALOX-5; arachidonate 5-lipoxygenase; APC,
Antigen presenting cell, BCG, Bacille Calmette Guerin; COX 1/2 cyclooxygenase
1/2; CTL, C-type lectin; DC, dendritic cell, DC-SIGN, dendritic cell-specific
intercellular adhesion molecule-3-non integrin; FcR, Fc Receptor; HAART,
Highly active antiretroviral therapy; HSC, haemopoietic stem cells; IRIS, immune
reconstitution inflammatory syndrome; IgG, Immunoglobulin G; i-RHOM2,
inactive rhomboid protein2; LTA4H, Leukotriene A4 hydrolase; LTB, leukotriene
B; LXA4, lipoxin A4; ManLam, mannose-capped lipoarabinomannan; MARCO,
macrophage receptor with collagenous domain; MCL, macrophage C-type lectin;
Mincle, macrophage inducible Ca++-dependent lectin; Mm, mycobacterium
marinum; MPS, mononuclear phagocyte system; MTB, mycobacterium
tuberculosis; NLR, nod-like receptor; N-Ramp, natural resistance associated
macrophage protein; PGE2, prostaglandin E2; PPAR, peroxisome proliferator
activated receptor; SP-A, Surfactant protein-A; SR-A, Scavenger receptor A;
STING, stimulator of interferon genes; TB, tuberculosis; TNF, tumor necrosis
factor; TLR, Toll-like receptor; TRegs, regulatory T lymphocytes.
FIGURE 1 | Ontogeny of mouse lung macrophages shapes the outcome of
initial MTB infection in vivo. Adapted from Huang et al. (2018), who compared
the role of alveolar macrophages (AM), of embryonic origin, with mainly
monocytic, bone marrow-derived interstitial macrophages (IM) in acute
infection of mice by fluorescent MTB reporter strains. Bacilli in AM, deriving
energy from fatty acid oxidation, grew more readily than IM, which were
actively glycolytic, more restrictive and expressed M1-like rather than M2-like
markers of macrophage activation. The authors favored a model of
pre-programming, linked to ontogeny, rather than adaptation to the distinct
local microenvironment. There is suggestive, but no direct, evidence in
humans that alveolar and other tissue-resident macrophages are of embryonic
origin. This conclusion is based on transplantation studies of donor and
recipient macrophages in skin (Bigley et al., 2011) and small intestine (Bujko
et al., 2018), and evidence of local turnover in lung rather than bone marrow
origin. It is not known which plasma membrane receptors mediate uptake of
MTB in this in vivo model. Alveolar macrophages in the mouse express low
levels of F4/80 and of CD11b, and high levels of several plasma membrane
receptors: lectins such as the mannose receptor (CD206), and the Scavenger
Receptor AI/II and MARCO, which are involved in the uptake of inhaled
particles such as MTB (Gordon et al., 2014a). Other widely studied lectins
expressed by lung macrophages include the FcRgamma-coupled receptors
Dectin-2, Mincle and MCL, as well as Dectin-1, Mannose Receptor and
DC-SIGN (Marakalala and Ndlovu, 2017).
Bone marrow-derived monocytes are themselves
heterogeneous within the circulation, where they can remain,
enter tissues constitutively or be recruited in response to
a variety of sterile or infectious stimuli. They are loosely
described as inflammatory, elicited or recruited monocyte-
derived macrophages, and are known to display markedly
different properties to those of tissue-resident macrophages.
In response to poorly understood local environmental stimuli,
e.g., in the lung, liver, gut, brain and skin, these macrophage
populations adopt different tissue-specific phenotypes (Lavin
et al., 2014), which can influence the outcome of MTB infection.
As described below and shown schematically in Figure 1, Russell
and colleagues have used a pulmonary infection model in the
mouse to establish for the first time, the importance of the
distinction between embryonic and bone marrow origin of lung
macrophages in determining the outcome of initial infection by
MTB (Huang et al., 2018).
Frontiers in Microbiology | www.frontiersin.org 2 May 2018 | Volume 9 | Article 1028
Marakalala et al. Macrophage Heterogeneity in the Immunopathogenesis of Tuberculosis
Recent population and single cell analysis of macrophages,
in situ and ex vivo, illustrate the extensive heterogeneity of
plasma membrane receptor (Gordon and Plüddemann, 2017)
and biosynthetic gene expression (Lavin et al., 2014), of
macrophages in the steady state and in various intracellular
infection models. In addition, macrophages in different organs
express distinct tissue-specific phenotypes, as well as canonical
genes shared by macrophages in different tissues (e.g., Lavin
et al., 2014). Intriguingly, phagocytosis of apoptotic cells
downregulates inflammatory responses irrespective of tissue
macrophage location (reviewed in Gordon and Plüddemann,
2018). Conversely, Avraham and colleagues have shown that
pathogen cell-to-cell variability drives Type 1 Interferon
production by individual macrophages in a Salmonella model;
this was ascribed to PhoPQ activity in the population of invading
bacteria that modified LPS in a subset of organisms (Avraham
et al., 2015). Similarly, Saliba et al. (2017) demonstrated by
single–cell RNA-seq analysis that heterogeneity of bacterial
growth rate in individual macrophages could be correlated with
different macrophage gene expression profiles.
Similar variability in both pathogens and macrophages could
give rise to marked heterogeneity in susceptibility or resistance
to TB encounters at body surfaces such as lung, skin and gut,
in serosal cavities e.g., the pleura, pericardium and peritoneum
(Rosas et al., 2014; Okabe andMedzhitov, 2016;Wang andKubes,
2016), and within the blood or lymphatic circulation (Gordon
et al., 2014b). At present, we know little about the impact
of microbial heterogeneity and local and regional diversity of
macrophages, on the initiation, dissemination and outcome of
TB, well described in the early pathology literature. The mixed
origin of MPS populations is further enhanced by mobilization
from tissue reservoirs such as the spleen (Swirski et al., 2009) or
the peritoneal cavity (Wang and Kubes, 2016), and by dynamic
modulation of a spectrum of different cellular phenotypes,
loosely described as “activation.” Organ-specific properties
clearly relevant to pulmonary infection include the role of GM-
CSF in alveolar macrophage development (Guilliams et al., 2013),
their interactions with surfactant proteins and lipids (Hussell and
Bell, 2014), as well as impact of the oxygen-rich environment and
inhaled particulates. Moreover, the bone marrow, gut, liver and
brain, for example, contain multiple subpopulations of resident
macrophages, with different, but still largely undefined tissue-
specific properties which will affect their response to MTB; these
include differences in metabolism, microbicidal/microbistatic
activity, persistence, latency and reactivation of infection. In
addition, the presence of other micro-organisms, whether
commensals or pathogens, can have a profound impact on
macrophage-mycobacterial interactions. This is well illustrated
in HIV/AIDS, a major co-pathogen of Tuberculosis, but subtler
interactions with organisms in the microbiome of the gut,
skin and lung, for example, and with antibiotics need further
study. A particular illustration of genomic diversity of MTB
as a result of spread within the lung as well as to extra-
pulmonary tissues was provided by analysis of HIV-associated
Tuberculosis at autopsy in subjects who had received minimal
antitubercular treatment (Lieberman et al., 2016). Selection in
individual patients resulted in co-existence of substrains for long
periods, giving rise to repeated dissemination within, rather than
new infections between individuals. It is not known whether this
can also occur in the absence of AIDS.
In the present review we focus on macrophage properties
relevant to the pathogenesis of tuberculosis during both innate
and adaptive immunity to infection; further references can be
found in recentmulti-author volumes published by the American
Society of Microbiology (Gordon, 2017; Jacobs et al., 2018);
individual chapters are available in Microbiology Spectrum. We
do not cover the role of polymorphonuclear leukocytes(PMN)
andDendritic cells(DC), except in passing.Box 1 summarizes the
role of T lymphocytes in granuloma formation and macrophage
effector functions. The potential roles of B lymphocytes and
humoral responses including antibodies are beyond the scope of
this review.
MTB TROPISM FOR MACROPHAGES,
ENTRY AND RESPONSES
The microbiology of MTB is under intense study, with emphasis
on its metabolism, growth and unique constituents, such
as complex surface glycolipids (Jackson, 2014), known to
influence cellular infection. Although to a great extent tropic
for macrophages and DC, it is clear that other cell types such
as adipocytes are also infectible by MTB, as discussed below.
Neutrophils can and do take up MTB, whether opsonized
or not, and may die by pyroptosis as well as apoptosis.
Human neutrophils which undergo MTB-induced necrosis can
be ingested by macrophages (Dallenga et al., 2017) and MTB
also replicates within necrotic human macrophages (Lerner
et al., 2017, 2018). Recent studies have reported that activated
macrophages can generate extracellular traps (METOSIS),
comparable to, but distinct from NETOSIS (Doster et al., 2017).
Although there have been many attempts to identify the
macrophage plasma membrane receptors responsible for MTB
tropism, we still lack a clear understanding of the role of
particular receptors and their heterogeneous expression by
different tissue macrophage populations. This can be due to
receptor redundancy, the low affinity of individual receptors,
variable expression by different macrophages, in vivo, including
species differences, and the presence of opsonins, rather
than direct receptor-mediated uptake. The lectin-like mannose
receptor (CD206) recognizes ManLam on MTB; its role in MTB
uptake has been studied in considerable detail by Schlesinger and
his colleagues (Kang et al., 2005). Other lectins that play a possible
role in MTB infection of macrophages (Wilson et al., 2015;
Rajaram et al., 2017) including Mincle (Ishikawa et al., 2009) and
MCL; Beta2 integrins (CD11b/CD18) and Scavenger receptors
such as MARCO and CD36, have also been implicated (Dodd
et al., 2016). Siglecs (Crocker et al., 2007) expressed by a variety of
immune cells, including macrophages, are sialic acid recognition
sensors; desialylation of complex glycoconjugates can expose
galactosyl residues, ligands for galectins (Sundblad et al., 2017).
Identification of the contribution of particular receptors is
complicated by the role of many of these macrophage surface
receptors in clearance of apoptotic and necrotic cell targets,
which are abundant in MTB infection and may even serve as
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BOX 1 | Adaptive immunity.
The adaptive immune response, mainly comprised of antigen specific CD4+ cells, plays a critical role in the outcome of M. tuberculosis infection (Jasenosky et al.,
2015). For robust control of the infection, T cells need to arrive timeously at the right site where they can interact with heterogeneous subpopulations of DCs, derived
from circulating monocyte precursors and mature monocytes in blood (Austyn, 2016; Villani et al., 2017). Monocytes, essential effector cells in adaptive as well as
innate immunity, are themselves heterogeneous and contribute to granuloma supply and demand at the core of the necrotic granuloma (Randolph, 2015; Pagan
and Ramakrishnan, 2018). Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 on antigen presenting cells (APC) (Schaible et al.,
2003). Typically, MTB- specific T cells become detectable at least 3 weeks after infection. In many TB models, establishment of the T cell immune response coincides
with the arrest of bacterial replication (Flynn, 2006), indicating a significant role of adaptive immune T cell dependent—macrophage interactions in TB control. Two
CD4+ T cell phenotypes essential for MTB control are Th1 and Th17 responses. Th1 immunity is characterized by the release of IFN-γ that activates macrophage
microbicidal activities. IFN-γ is essential for anti-mycobacterial defense in mice (Flynn et al., 1993), and polymorphisms in the IFNG gene are associated with MTB
infection risk and disease progression in humans (Rossouw et al., 2003). Th17 differentiation is driven by IL-23, and is characterized by the release of IL-17, which
is critical for early recruitment of neutrophils to the site of infection (Freches et al., 2013). IL-17 has been shown to be required for protection against TB in mice
infected with a hyper-virulent clinical isolate M. tuberculosis HN878 strain. Mice deficient in this cytokine had significantly higher bacillary burdens and less organized
granulomas (Gopal et al., 2014). At excessive levels, however, IL-17 promotes tissue pathology and inflammation, suggesting that tight regulation of this cytokine is
required during infection (Das and Khader, 2017). Foxp3+ T regulatory cells (Tregs) dampen Th1 immunity through inhibition of inflammatory cytokines by IL-10. Treg
frequencies are higher in peripheral blood and at disease sites of patients with active TB, where they suppress production of MTB-specific IFNγ by Th1 cells ex vivo
(Marin et al., 2010); too much expansion of these cells may result in impaired immunity.
The role of Th2 responses in TB infection is controversial. Mice deficient in IL-4, IL-4Rα, or STAT6 on a C57BL/6 background display disease outcomes similar to
wild-type mice infected with MTB (North, 1998; Flynn and Chan, 2001; Jung et al., 2002). However, IL-4 seems to be detrimental in a BALB/c mouse background,
with its deletion resulting in more protection against TB infections. Also, antibody neutralization of IL-4 on this background provides protection against chronic TB
infection. Mechanisms associated with the detrimental role of Th2 cytokines remain unclear, but may stem from their ability to inhibit Th1 factors such as TNF,
required to control bacterial replication (Hernandez-Pando et al., 2004). IL-4 is expressed in human surgically-derived lung tissues (Stanton et al., 2003), although
its function in humans has not been established. Over-expression of another Th2 cytokine, IL-13, in mice, results in susceptibility to TB infection characterized by
enhanced collagen deposition and enhanced lung pathology with necrotizing granulomas (Heitmann et al., 2014). These studies suggest that the IL-4/IL-13 axis
drives pathological damage. A recent report by Minutti et al. (2017) has identified SP-A in the lung as a tissue-specific amplifier of IL-4-dependent macrophage
proliferation and activation.
In granulomas, T cells constitute a larger part of the outermost layer. However, it is poorly understood how CD4+ T cells or IFNgamma penetrate lung lesions to
access macrophage-rich areas at the centers. The Kaufmann laboratory has shown that chronic infection in both mice and humans is associated with the development
of lymphoid follicle-like structures at the periphery of granulomas to orchestrate local host defense in the lung (Ulrichs and Kaufmann, 2006; Kahnert et al., 2007). They
identified two layers surrounding the necrotic centers; the first, an inner layer that comprised CD68+ APCs and large cells, including epithelioid and Langhans giant
cells. This layer also contained the bacilli, and CD4+ and CD45RO+memory cells. The second layer was the outer area of the lesions, characterized by infiltration of
B and T cells. This outer-most layer was enriched with CD8+ T cells, largely absent in the inner layer (Ulrichs and Kaufmann, 2006). Thus CD4+ and CD8+ T cells
seem to exhibit distinct spatial distribution in a granuloma structure.
The importance of CD8T cells in the long-term control of infection has been demonstrated using several mouse strains deficient in CD8T cells due to different gene
deletions (Lin and Flynn, 2015), but little is known about colocalisation of CD8T cells and macrophages in granulomas. Depletion of this subset of cells in TB-infected
mice results in an increased bacterial burden (van Pinxteren et al., 2000). The requirement for CD8T cells was also shown in macaque models of TB, with some
research indicating that the depletion of CD8T cells in BCG-vaccinated macaques results in compromised control of MTB infection (Chen et al., 2009). Although
more research is required in humans, data from macaques support the importance of CD8 cells in TB (Lin and Flynn, 2015). Other T cell subsets involved in immune
responses to MTB infections and potential interactions with macrophage subpopulations include γδ T, innate lymphoid cells, NK and CD1-restricted CD4/CD8 double
negative T cells (Jasenosky et al., 2015; Ndlovu and Marakalala, 2016).
The role of B cells and antibodies in TB remains largely unclear (Achkar et al., 2015); antibodies mediate potent effector mechanisms through macrophage Fc and
Complement receptors and activation of their microbicidal mechanisms.
potential Trojan horses for infection. These include Phosphatidyl
Serine (PS) recognition molecules MerTK, axl (prominent in
alveolar macrophages), their opsonic cofactors such as Gas and
protein S, as well as other opsonins such as lactadherin (MFGE8),
annexin, calreticulin, SP-A, and C1Q (Gordon and Plüddemann,
2018). Known MTB ligands for Mincle and MARCO include
trehalose dimycolate (TDM, cord factor). Mincle together with
MCL engages TDM to induce production of inflammatory
cytokines such as IL-6, TNF, and IL-1beta (Ishikawa et al., 2009;
Miyake et al., 2013). Dectin-2, DC-SIGN, and Mannose Receptor
all recognize mannose-capped lipoarabinomannan (ManLAM)
on the surface of MTB (Yonekawa et al., 2014; Marakalala and
Ndlovu, 2017). Dectin-1, a major receptor of fungal beta-glucans
that signals through the adaptor molecule CARD9, which is
essential for tuberculosis control in the mouse (Dorhoi et al.,
2010), has also been demonstrated to recognize an unknown
ligand on the surface of MTB. This may differ from the well
characterized beta-glucan ligand for Dectin-1 on fungi; such a
ligand has been detected in selected tumor cells, and may be
masked by N-glycans (Chiba et al., 2014).
Macrophage receptor-TB interactions result in activation of
numerous cellular responses (Marakalala and Ndlovu, 2017).
These molecules, however, are largely redundant in the in vivo
control of chronic TB infection in mice and nor is it known
which receptors are responsible for MTB uptake by the different
macrophage subpopulations in granulomas, in situ, and for
their resultant responses. For example, Dectin-1 knockout mice
mount the same immune response as wild-type mice (Marakalala
et al., 2011), whereas Dectin-2 has not yet been studied in an
MTB in vivo model. MCL seems to drive a moderate protective
role, while contradictory results have been reported for Mincle
and DC-SIGN (Marakalala and Ndlovu, 2017). Future research
should explore potential cooperation (Bezbradica et al., 2014)
between individual CLRs, their synergy with other receptors
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such as TLRs and potential scaffold proteins in lipid rafts,
and how this might affect the outcome of TB disease in vivo.
Studies in human populations should confirm or identify novel
dominant or recessive genetic susceptibility toMTB infection and
BCG.
Macrophages express a range of plasma membrane and
endosomal receptors for uptake of MTB components; exchange
of mycobacterial and host-derived lipids is considered further
below. Contrasting results have been reported on the role of TLRs
in TB. TLR-2 and TLR-4, for example, have been shown to play a
role in the long-term control of M. tuberculosis (Jo, 2008). Some
studies, however, have reported that TLR2/4/9–/– triple knockout
mice mount the same T cell mediated immune response
compared with WT mice after infection with MTB (Holscher
et al., 2008). Macrophages and other myeloid leukocytes express
activatory and inhibitory FcR for IgG, as well as CR3 and
other regulatory receptors for complement and antibody-coated
immune complexes; these play a potentially important role in
their endocytic and cytotoxic responses. Cytosolic sensors of
MTB constituents and nucleic acids have been shown to play
an important role in macrophage responses to MTB infection.
For example, the nucleotide-binding oligomerization domain
protein NOD2 has been shown to synergize with TLR-2 for
the production of pro-inflammatory cytokines in response to
live MTB (Jo, 2008). Another widely studied cytosolic sensor is
the NLRP3 inflammasome, which induces IL-1beta processing
and pyroptosis through caspase-1. Mishra et al have linked the
NLRP3 inflammasome with lung pathology in TB infection,
which can be regulated by NO (Mishra et al., 2013). Another
report, however, has demonstrated that the inflammasome is
not linked to the disease outcome (Walter et al., 2010). The
recognition of MTB DNA will be described below after first
considering the membrane dynamics and fate of the MTB
phagosome in macrophages.
D’Arcy Hart and colleagues (Goren et al., 1976) first
reported that MTB inhibited phagosome-lysosome fusion and
acidification within the vacuolar compartment in which they
resided after uptake, an important evasion mechanism for this
intracellular pathogen. The question of entry to the cytosol
by mycobacterial constituents and potential antigens for CD8
cytotoxic T lymphocytes has been under considerable debate
for some years. It is likely that macrophage activation by
CD4T lymphocyte- and NK–dependent Interferon gamma
overcomes both the fusion and acidification block. Macrophages
are not only active endocytic and phagocytic cells, but also
highly regulated secretory cells (Nathan, 2012), characterized
by extensive membrane flow, selective intracellular fusion of
vesicular membranes, fission and recycling (Tan and Russell,
2015). It is not known in detail how membrane traffic is
selectively altered by MTB, and the impact of autocrine and
paracrine effects of cytokines such as TNFalpha must also be kept
in mind (Caldwell et al., 2014). Small GTPases play an important
role in regulating intracellular survival of Mycobacteria in mouse
macrophages; there are significant species differences in this
regard (Gazzinelli et al., 2014). Another, genetic, difference in
mouse susceptibility to infection relates to N-Ramp1 (Natural
resistance-associated macrophage protein,1), a member of a
metal ion transporter family at the interface between the
phagolysosomal compartment and the cytosol (Buschman and
Skamene, 2001; Blackwell et al., 2003). Recent studies with
other Gram negative and Gram positive bacteria have described
a role for a family of Copper-binding molecules (Burstein
et al., 2005; Phillips-Krawczak et al., 2015) which participate
in cytosolic multi-protein complexes and interact with the
phagocytic pathway, lysosomal biogenesis and inflammasome
activation. Their role in MTB infection has not been defined.
Russell (Tan and Russell, 2015), Grinstein (Fairn et al., 2009), and
their colleagues have made important contributions to studying
acidification mechanisms in macrophages, and their role in anti-
TB drug development, which requires screening within living
macrophages and not in isolation. The interaction of MTB
and the autophagy pathway (Deretic and Klionsky, 2018) has
also attracted considerable attention, bearing on macrophage
death and its role in immune activation and pathogenesis, as
well as on mycobacterial survival and latency. Live imaging
of spatiotemporal dynamics of MTB phagosomes has revealed
that effective control of MTB replication in IFN-γ activated
macrophages requires appropriate spaciousness of proteolytic
phagosomes whose generation and membrane integrity are
maintained by a Rab20-dependent membrane traffic pathway
(Schnettger et al., 2017). Further studies on the proteome of
isolated phagosomes from infected and uninfected cells as well
as super resolution and intravital microscopy will help to clarify
the complex interplay between the macrophage and its infectious
cargo (Mahamed et al., 2017; Schnettger et al., 2017).
Intracellular bacteria, viruses and parasites have evolved a
variety of different strategies to survive within macrophages;
TB provides a particularly challenging infection model of great
interest to cell biologists, microbiologists and immunologists.
Although there has been an explosion of knowledge bearing
on cytosolic sensing and intracellular signaling mechanisms
of bacterial membrane molecules (NLRs) and nucleic acids
(RIG-I, STING), the recognition of mycobacterial constituents
by these intracytoplasmic protein complexes remains largely
unknown. Direct detection of cytosolic MTB DNA by cGAS
has been demonstrated by Watson et al. (2015). Unlike Listeria
monocytogenes which produces the STING agonist cyclic-di-
AMP, cGAS (cyclic GMP-AMP synthase) is required to activate
type1 interferon by cytosolic DNA of MTB and Legionella
pneumophila, via the STING/TBK/IRF3 pathway. Human
genetic auto-inflammatory syndromes andmouse genetic models
should have much to teach us in this regard.
GRANULOMA FORMATION IN THE LUNG
Alveolar macrophage infection is an important and well-studied
initiator of granuloma formation. As noted above, they are
exposed via the airway to MTB, which they capture and sense
through plasma membrane, endosomal and cytosolic receptors.
They generate antigens and interact with DC, which are required
to activate naïve T lymphocytes, although macrophages can
activate primed T cells (Austyn, 2016). Alveolar macrophages
communicate with local epithelial cells to maintain gas exchange
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and set the threshold and the appropriate quality of the immune
response. Macrophage populations in the lung are heterogeneous
in their initial embryonic and subsequent bone marrow origin;
monocyte recruitment to the lung is enhanced by exposure to
particulates and pollutants that reach the lower airways (Torrelles
and Schlesinger, 2017). As described above and in Figure 1,
Russell and colleagues have demonstrated that ontogeny
contributes to the interaction and outcome of initial MTB
infection in the mouse (Huang et al., 2018). The authors favor
a pre-programmed model ascribed to developmental origin,
rather than responses to different local microenvironments. The
receptors that mediate acute infection in this in vivo model
were not defined. Apart from exposure to local surfactant
proteins, potential opsonins and high levels of oxygen in the
microenvironment are other macrophage modifying factors.
Surfactant proteins A and D contribute to innate immunity
outside the lung as well as within the alveolar space and may
also contribute to extra-pulmonary TB (Ujma et al., 2017). The
lung contains other specialized populations such as interstitial
macrophages, that are not directly exposed to exogenous alveolar
stimuli; these include intra-epithelial macrophages and DCs,
found mostly in larger airways, and macrophage populations in
the pleural cavity (Gordon et al., 2014a; McClean and Tobin,
2016). Alveolar macrophages undergo tissue imprinting in the
lung as a result of their unique environment and exposure to
infectious agents via the airways (Hussell and Bell, 2014). Other
cells that are involved in the early response to TB infection
are PMNs, which are the first defensive cells to be recruited to
tissue during infection. PMNs have been reported to be the most
abundant infected cells in the airways, sputum and BAL from
patients with active TB.
Heterogeneity in TB Granulomas
The overall composition and fate of granulomas have been
briefly described above, with emphasis on the heterogeneity of
macrophage origin, anatomic location and phenotypes. Here
we consider heterogeneity of MTB-induced granulomas in
the lung. Recent data in human disease and primate models
have shown that infected individuals contain a heterogeneous
mixture of granulomas in various histologic states, with varying
degree of immune activation, macrophage immune-phenotypes
and the ability to control bacterial replication (Stanton et al.,
2003; Kim et al., 2010; Lin et al., 2014; Gideon et al., 2015).
Also, some important immune pathways seem to be distinctly
enriched in specific regions within granulomas (Marakalala
et al., 2016). This body of research suggests that disease-driving
processes are compartmentalized within individual granulomas,
and that these spatial processes may be linked to the clinical
outcome. Our understanding of granuloma organization has
come mostly from histopathology, which assesses structure by
the abundance of various cell-types (Ulrichs et al., 2004; Gideon
et al., 2015). Histological analyses of human TB have provided
evidence for morphologic heterogeneity among pulmonary
alveolar macrophages, foam cell formation, epithelioid cells and
multinucleated giant cells (Figure 2; Dannenberg and Rook,
1994). Distinct phenotypes and activation status of macrophages
in human pulmonary granulomas have also been demonstrated
by immunohistochemistry with a panel of antibodies (Stanton
et al., 2003). However, more research is still required for
better understanding of macrophage differentiation, cell-to-
cell interactions, heterogeneity and functions within various
compartments of TB granulomas.
With the availability of new advanced techniques, research on
the role of granulomas in TB has received considerable attention
recently, withmany advanced genome-wide approaches explored
to give a better molecular characterization of the macrophage-
rich structures. Using a combination of laser microdissection and
microarray analysis of human lung tissues, a study by Kim et al.
(2010) demonstrated that genes involved in lipid sequestration
and metabolism were highly expressed in caseous granulomas.
Immunohistochemical analysis of the tissue confirmed the
upregulation of proteins involved in lipid metabolism in
cells surrounding the caseum, including adipophilin, acyl-CoA
synthetase long-chain family member 1 and saposin C.
In a similar approach, Marakalala et al. (2016) utilized
proteomics and mass spectrometric imaging to characterize
spatial organization of inflammatory pathways within human
granulomas. The centers of the granulomas were concentrated
with pro-inflammatory and antibacterial signatures whereas
the cellular peripheries were enriched with anti-inflammatory,
tissue-preserving mediators (Marakalala et al., 2016). A similar
phenomenon has been shown in granulomas from macaques,
in which spatial delineation and inflammatory cell programmes
were organized around distinct subsets of macrophages (Mattila
et al., 2013). These studies suggest that local balance of pro-
and anti-inflammatory responses may determine the fate of
individual granulomas, which collectively influence the host
response (Marakalala et al., 2016). The model proposed by
these studies may also help to explain the heterogeneity that is
often observed in TB granulomas, even within the same host,
as differences in inflammatory responses probably contribute
to diverse granuloma structures and functions (Cadena et al.,
2017). In macaques, Lin et al demonstrated that the majority
of granulomas begin with a single bacterium (Lin et al., 2014).
The authors observed variability in bacterial killing within
individual granulomas that was independent of host status.
These findings established that local events at granuloma level
are likely to influence the clinical outcome of infection. To
understand the repertoire of the adaptive immune system in
various granulomas, Subbian et al. examined lung granulomas
from patients with chronic pulmonary TB (Subbian et al., 2015).
The study revealed significant variability in T cell density and
fibrosis. Gideon et al reported variability in different factors
even within the same macaque (Gideon et al., 2015). These
factors included the total numbers and phenotypes of T cells, the
numbers and heterogeneity of macrophages and a wide range of
cytokine profiles and bacterial burdens within each granuloma.
The majority of these T cells produced only a single cytokine;
dominant cytokines included IFNγ, interleukin-2 (IL-2), Tumor
Necrosis Factor (TNF), IL-10, and IL-17. These findings suggest
that granuloma heterogeneity and spatial organization of cellular
and humoral host responses at granuloma level should be taken
into account when designing host-directed therapies that limit
lung pathology.
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FIGURE 2 | Phenotypic heterogeneity of macrophages induced by MTB infection in vivo. Macrophages are able to undergo remarkable variations in their phenotype
in vivo, yet the mechanisms are poorly understood. This is partly the result of species variation, inadequacy of defined in vitro conditions to mimic in vivo phenotypes,
limited population and single cell analysis of cells in situ or after extraction, ex vivo, and above all, the complexity and heterogeneity of the mixed populations present in
tissues. Variables that have been characterized to some extent, include: ontogeny (embryonic or bone marrow origin); steady state and physiological conditions in
different organs and microenvironments; sterile injury and acute or chronic infections such as MTB; cell recruitment, phagocytosis and activation by different
exogenous and endogenous stimuli; and cell death by apoptosis, necrosis or pyroptosis. In many situations the macrophage phenotype covers a spectrum of
responses, rather than binary alternatives. Their characterization is morphological, utilizing combinations of marker antigens, signatures of gene expression, and,
where known, functional differences. The text provides examples of the different phenotypes illustrated here. The impact of macrophage phenotype on MTB infection,
and conversely, of MTB infection on macrophage functions is barely understood.
Epithelioidisation of Macrophages Within
Granulomas
Macrophages can undergo a series of morphological changes
characterized by cytoplasm expansion and interlocking between
membranes of neighboring cells. Macrophages undergoing this
histological transformation have always been termed epithelioid
cells (Dannenberg and Rook, 1994), although their significance
in granuloma functions remains unclear. Recent work by Cronan
et al. has meticulously described molecular underpinnings of
macrophage epithelialization within granulomas (Cronan et al.,
2016). Using a zebrafish model, immunofluorescence and live
imaging techniques, the authors showed that as macrophages
create junctions with each other to form a tuberculous
granuloma, they express and deploy adherens components. The
macrophages expressed proteins that are typically associated with
epithelial cells, including desmosomal proteins (desmoplakin,
desmoglein, and desmocollin), adherens junction proteins (E-
cadherin, plakoglobin, α-, β-, and δ- catenin), and tight junction
pathways (ZO-1 and ZO-2). Proteins corresponding to these
genes have been identified in a proteomic survey of granulomas
from humans infected with MTB (Marakalala et al., 2016). A
significant finding from the study by Cronan and colleagues
is the observation of epithelial markers in the epithelioid
cells of granulomas. Taken together, these studies underpin
epithelioidisation of tissue macrophages as a fundamental
process in granuloma development and the ability to control




BCG has provided a potent adjuvant to study for its own sake as a
vaccine, as well as providing a tool to induce innate and adaptive
immune activation of macrophages. Mackaness and colleagues
performed now-classic studies on the role of BCG administration
in mice, in order to induce enhanced resistance, not only
to BCG, but also non-specifically to an unrelated challenge,
e.g., Listeria monocytogenes, and vice versa (Carter, 2014).
Building on earlier pioneering discoveries by Koch and Ehrlich,
as well as Metchnikoff, the Mackaness group confirmed that
this mechanism, now termed “Classical macrophage activation,”
was cellular and not humoral in origin. Subsequent studies
identified Interferon gamma as the major cytokine produced
by specific CD4T lymphocytes or by innate NK cells. The
role of IL-12 and IL-18, and various cytokine receptors on
macrophages was elucidated by several investigators; these
studies complemented the discovery by Casanova (Casanova
and Abel, 2017), Holland (Wu and Holland, 2016) and others
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of primary immunodeficient patients unable to control BCG
infection after immunization with live BCG or after infection by
relatively avirulent organisms. Studies by Nathan (Nathan, 2013)
and others established that the induction of inducible nitric oxide
synthase (i-NOS) and generation of antimicrobial nitrogen-
based radicals, combined with oxygen radicals generated by
the respiratory burst, contributed to anti-microbial resistance
in mice. After some technical issues, the role of NO in
human infection byMTB was confirmed. Subsequent microarray
analysis by several research groups revealed a signature of gene
expression in mouse and humans after IFN gamma activation of
macrophages, distinct from the “alternative activation” signature
induced by the Th2 cytokines IL-4 and IL-13, acting through
the common IL-4R alpha chain receptor. Nathan’s group
also documented potent metabolic anti-oxidant defenses in
macrophages. Vitamin D induces antimicrobial peptides and
autophagy in monocyte/macrophages and promotes resolution
of inflammation in TB patients (Fabri et al., 2011; Coussens
et al., 2012). Glucocorticosteroids have potent inhibitory effects
on inflammation, monocyte recruitment and activation of
macrophages by MTB.
There is evidence that TB infection in humans induces IL-4
gene expression in macrophages (Stanton et al., 2003), possibly
mediated by TLR involvement, the spectrum of gene activation
that is upregulated indicates a more mixed activation signature
than in laboratory mouse strains. The initial binary classification
of M1- and M2-types of macrophage activation by IFN gamma
and IL4/13 respectively has been refined to a broader spectrum
of activation, in which individual markers are replaced by a
signature of a group of genes, many of which overlap with
altered gene expression by other defined stimuli. Alternative
activation of macrophages has been implicated in tissue repair
and fibrosis; whether this plays a role, together with transforming
growth factor beta, in Tuberculosis-induced fibrosis remains
to be elucidated. Although Th2 cytokines readily induce
macrophage cell-cell fusion in vitro and in vivo, the mechanism
of Langhans giant cell formation (Figure 2), a characteristic
feature of human tuberculosis, remains obscure. Interferon
gamma by itself does not promote fusion in vitro, but may
contribute to macrophage fusion in combination with ligation
of uncharacterized macrophage plasma membrane glycoproteins
(Sakai et al., 2012), GM-CSF and fusogenic MTB (Puissegur
et al., 2007) and host lipids. An alternative mechanism, DNA
injury and failure of cytokinesis has been proposed to account
for multinuclear giant cell (MNGC) formation in tuberculosis
(Herrtwich et al., 2016). The functional significance of Langhans
giant cell formation, especially in relation to interactions with
MTB, remains unclear, Studies on IL-4 induced MNGC have
revealed enhanced clearance of large particulates and systemic
amyloid deposits in vivo; this was associated with selective
activation of CR3 function, as a result of cell fusion (Milde
et al., 2015). Recent revival of interest in macrophage metabolism
has provided evidence that classically and alternatively activated
macrophages utilize glycolysis and oxidative phosphorylation,
respectively (O’Neill and Pearce, 2016), as their main source
of energy. Shi et al have reported that infection with MTB
induces the Warburg effect in mouse lungs (Shi et al., 2015).
Gleason, O’Neill and Keane have shown that enhanced aerobic
glycolysis in human alveolar macrophages is required to control
intracellular bacillary replication (Gleeson et al., 2016).
As an adjuvant, BCG has been utilized to boost anti-cancer
immunity, with some success in bladder cancer after local
administration (Alexandroff et al., 1999). This could benefit
combination therapy with antibody-based checkpoint therapy
targeting T lymphocyte co-stimulatory receptors. Extending
earlier findings that BCG could prime macrophage activation,
Netea and colleagues (Arts et al., 2018) have used BCG as one
of their protocols to induce “trained immunity,” ascribed to
epigenetic mechanisms. Yeast particles, taken up bymacrophages
through the beta-glucan receptor, Dectin-1, which signals
through syk and Card9, provides a similar priming function. As
information accumulates from GWAS and SNP studies, other
genes than those mentioned above and the MHC complex may
be found to contribute to human macrophage activation.
PROTEIN SECRETION BY ACTIVATED
MACROPHAGES: ROLE IN
PATHOGENESIS OF TUBERCULOSIS
It is only since the early 70’s, from the description of lysozyme
secretion by mouse macrophages in cell culture (Gordon et al.,
1974), that it was recognized that macrophages are not only
professional phagocytes, but also highly active secretory cells.
Mature macrophages do not accumulate preformed proteins
in granules as do granulocytes, for immediate release in
acute inflammation. Low molecular metabolites derived from
oxygen during the respiratory burst and from preformed
lipids during acute inflammation can be rapidly generated
from arachidonates in the plasma membrane, but proteins
are newly synthesized, consistent with their required functions
in prolonged inflammation, as well as in tissue homeostasis.
Macrophages produce a large variety of proteins in relatively
small amounts, e.g., all components of the complement cascade,
potentially significant in their immediate local environment.
Lysozyme is constitutively released by macrophages in culture,
although its production is greatly enhanced by chronic
inflammation and activation, as seen by in situ hybridization in
BCG granulomas (Chung et al., 1988). It is highly cationic, will
bind to host negatively charged proteoglycans, but enzymatic
activity seems restricted to bacterial wall rather than host
substrates, directly or after exposure, eg through complement
lysis, as in MTB. It is lost from plasma by filtration through the
kidney (MW 14 Kd), but can be elevated by increased numbers
of macrophages, as well as enhanced output per cell, as in
tuberculosis.
Activated macrophages produce neutral proteinases such as
urokinase, elastase, collagenases and other metalloproteinases,
implicated in fibrinolysis, tissue remodeling and degradation.
Caspases are released as a result of inflammasome activation;
recent studies have demonstrated a range of caspase functions
unrelated to cell death (Shrestha and Megeney, 2012). As part
of inflammatory regulation, macrophages also release alpha 1
antitrypsin and alpha 2 macroglobulin to inhibit proteolytic
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activity. More restricted cleavage can activate proenzymes,
e.g., Angiotensin-converting enzyme (ACE) (Bernstein et al.,
2013), or inactivate components of plasma protein cascades,
e.g., by carboxypeptidase action, a macrophage-specific enzyme
(Mahoney et al., 2001). The protein cross-linking enzyme
Transglutaminase 2, a conserved feature of alternative activation
of macrophages (Martinez et al., 2013), has been implicated in
MTB restriction by macrophages (Palucci et al., 2017), as well as
in fibrosis. FXIIIA, a distinct transglutaminase, also expressed by
macrophages, displays similar properties (McGovern et al., 2014).
Macrophages can release a large number of proinflammatory
(e.g., Type I interferon, TNF alpha, Interleukin 1 beta, IL-
12, IL-18, IL-6) and anti-inflammatory cytokines (IL-10 and
TGFbeta), and a range of CC, CXC and CX3C chemokines,
as well as expressing their receptors. Growth factors which
macrophages produce, and respond to, include M-CSF, GM-CSF
and Erythropoietin, as well as releasing vascular endothelial and
fibroblast growth factors.
Release of TNF alpha from the plasma membrane is mediated
by ADAM 17, a metalloproteinase; surface TNF is an essential
ingredient of granuloma formation (Fremond et al., 2005) and
may play a role in contact-dependent killing of viable, TB-
infected macrophages (Mahamed et al., 2017), whereas secreted
TNF may be important in catabolism and weight loss, with IL-6
(Flint et al., 2016). Recent findings by McIlwain et al (McIlwain
et al., 2012) and the Freeman group (Christova et al., 2013) have
shown that a Rhomboid family of multispan transmembrane
molecules, of which i-Rhom 2 is specific for macrophages, are
essential for Adam17- dependent release of TNF alpha from
the macrophage plasma membrane, and may also contribute to
chaperone activity in ER transport and in lysosomal stability.
Taken together, it is clear that macrophage secretory activity
plays a major role in granuloma formation and function. To
establish which macrophage genes are expressed at the single
cell level, both as message and protein, it will be necessary
to examine samples of TB-infected tissue in situ and ex vivo.
It will also be necessary to relate macrophage activities within
and among granulomas and to characterize heterogeneity of
macrophage sources and functions of different products within
lesions.
TYPE I INTERFERON AND TUBERCULOSIS
Macrophages are an important source of Type 1 Interferon
in inflammation. Studies by Berry et al. (2010) identified a
whole blood transcriptional signature in active TB patient
cohorts from the United Kingdom and South Africa. The
signature was dominated by IFNα/β-inducible genes, which
were overexpressed in neutrophils. It is likely that blood and
activated tissue macrophages are a major source of type I IFN
as well, since the type I IFN gene profile also correlated with
the extent of radiographic disease. Interestingly, the whole blood
IFN signature was diminished with successful TB treatment,
suggesting an association of the interferons with disease severity.
Additional studies have verified the potential detrimental role of
type I IFNs in TB (McNab et al., 2015).
A recent study by Zak et al investigated blood RNA expression
to predict progression from latent tuberculosis infection to
active disease (Zak et al., 2016). In the study, latently infected
South African adolescents were followed for 2 years. Blood
samples from latent infections that converted to active disease
were analyzed by RNA sequencing to identify genes that were
differentially expressed in comparison to the controls who did
not convert. A 16-gene signature was identified and validated
using quantitative real-time PCR (Zak et al., 2016). Interestingly,
the signature comprised interferon-inducible genes previously
identified as expressed in active tuberculosis (Berry et al., 2010).
This confirms that type I interferon signatures can be exploited
to predict disease progression in point of care testing.
MACROPHAGE EICOSANOIDS AND
TUBERCULOSIS
Macrophages are a major source of Arachidonate metabolites
which have been shown to be important regulators of
inflammation and the outcome of tuberculosis and granuloma
formation (Figure 3). Although the mechanisms driving type I
IFN-mediated disease progression are still poorly understood,
a few studies have suggested suppression of pro-inflammatory
cytokines and Th-1 immunity as a major factor. A study by
Mayer-Barber and colleagues demonstrated a detrimental role for
type I IFNs in TB infection in mice (Mayer-Barber et al., 2014);
inhibition of IFNalpha/beta reversed the detrimental effects of
type I IFNs. This response was dependent on the induction
of prostaglandin E2 (PGE2). Direct administration of this
prostanoid resulted in the control of bacterial infection through
inhibition of type I IFNs (Mayer-Barber et al., 2014). This study
indicated the importance of type I IFNs and manipulation of the
eicosanoid balance as a target for host- directed therapies.
Studies in mice and zebrafish models have linked the
eicosanoid pathways with various modes of macrophage death.
Virulent MTB H37Rv has been shown to drive macrophage
necrosis through the production of lipoxin A4 (LXA4), which
inhibits prostanoid synthesis and promotes mitochondrial
inner membrane perturbations. In contrast, prostaglandin E2
(PGE2) suppressed inner mitochondrial membrane damage and
inhibited macrophage necrosis in macrophages. Furthermore,
mice deficient in prostaglandin E2 synthase (PGES) had higher
lung bacillary loads compared with wild type mice, indicating
the protective role of prostaglandin E2 against mycobacterial
infections in the lung (Chen et al., 2008). ALOX5 knockout
mice, which cannot produce LXA4, undergomore apoptosis with
enhanced MTB-specific T cell responses (Divangahi et al., 2010),
and are more resistant to MTB infection (Bafica et al., 2005),
suggesting detrimental effects of LXA4 during infection. On the
other hand, mice deficient in COX-2 are more susceptible to
MTB infection, confirming an important role for prostanoids
(Mayer-Barber et al., 2014).
Using a zebrafish model, Tobin and co-workers studied
the contribution of eicosanoid mediators in response to
Mycobacterium marinum (Mm) infection (Tobin et al., 2010,
2012). The authors identified a critical role for the enzyme
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FIGURE 3 | Eicosanoids drive inflammatory responses that modulate macrophage cell death and TB disease outcome. Arachidonic Acid (AA) can be metabolized by
5-LOX to produce Leukotriene A4 (LTA4), which is a precursor of Leukotriene B4 (produced via an enzyme LTA4H) or Lipoxin A4 (produced via 12-LOX). Leukotriene
B4 (LTB4) induces pro-inflammatory responses and TNF expression, which in excess, promotes macrophage necrosis and granuloma caseation. Lipoxin A4 (LXA4) is
anti-inflammatory and associated with TNF deficiency and increased intra-macrophage bacterial growth. Balanced amounts of these pro- and anti-inflammatory lipid
mediators are required for optimal control of cell death and disease progression. AA can also be metabolized by COX-1/2 to produce Prostaglandin E2, which induces
macrophage apoptosis and promotes antimicrobial activities.
Leukotriene A4Hydrolase (LTA4H) in determining susceptibility
of zebrafish to infection. LTA4H is responsible for production
of Leukotriene B4, a pro-inflammatory eicosanoid that induces
the transcription of TNF. Excess LTA4H in Mm-infected
zebrafish led to early reduction of bacterial growth inside
macrophages. However, bacterial restriction was rapidly followed
by macrophage necrosis, which enabled bacterial replication in
the permissive extracellular milieu (Tobin et al., 2010, 2012).
These results suggest that LTA4H, through TNF production,
can dually mediate resistance and susceptibility to mycobacterial
infection (Roca and Ramakrishnan, 2013). Its absence leads
to TNF deficiency, resulting in increased bacterial growth
intracellularly, while its overexpression leads to excessive
production of TNF resulting in macrophage necrosis (Figure 3;
Tobin et al., 2012; Roca and Ramakrishnan, 2013). In human
tuberculous granulomas, LTA4H is abundant in necrotic regions,
where it colocalises with TNF (Marakalala et al., 2016). In
humans, the genetic status of LTA4H has been shown to be
critical for disease outcome in TB meningitis patients. Patients
who are homozygous for low or high LTA4H expression
alleles developed severe TB meningitis with reduced survival,
while those heterozygous for intermediate LTA4H expression
controlled the infection (Tobin et al., 2012). These findings
confirm a need for balance in inflammatory responses, much of
it orchestrated by metabolic changes in activated macrophages.
MACROPHAGE FOAM CELL FORMATION
AND CASEATION
Foam cell formation and caseation are hallmarks of human
tuberculosis, yet their genesis, lipid composition, and significance
for outcome remain poorly understood. Caseation could be
due to cell death, resulting from mycobacterial toxicity and/or
an exuberant host immune response, as well as altered
lipid metabolism. Possible mechanisms include mobilization
from lipid stores, endocytosis and deposition in macrophages,
enhanced synthesis, locally and systemically, and/or failure
to degrade accumulated lipids in macrophages. Macrophage
foam cells form readily after uptake of various protein-bound
lipids by a range of scavenger receptors, e.g., SR-A, CD36
and LDL receptors (Neyen and Gordon, 2014). Lipid droplets
arise by synthesis and export from the endoplasmic reticulum
to the cytosol, before becoming bound by vesicle membranes
(Figure 2). Macrophage synthesis, uptake and exchange of
lipids are regulated by transcription factors such as PPAR
gamma and cytokines released by T lymphocytes and adipocytes
(Daniel et al., 2011; Ouimet et al., 2016; Cambier et al.,
2017). Foam cells in mouse granuloma models have been
shown to express Wnt 6, involved in macrophage arginase1
induction and proliferation (Schaale et al., 2013). In addition
to MTB-macrophage interactions, there seems to be an axis
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of interactions among MTB, macrophages and adipocytes,
eg multinucleated macrophages are closely associated with
adipocytes in white adipose tissue crown-like structures (Touton
cells) and there is evidence that MTB can infect adipocytes
(Neyrolles et al., 2006; Agarwal et al., 2016). Lipids derived from
intracellular bacteria and/or plasma are potentially fusogenic,
contributing in addition to host cytokines to Langhans giant
cell formation. At a systemic level there is an association
between TB and diabetes, cachexia is a characteristic feature
of advanced TB, possibly mediated by TNF (originally named
cachectin) and IL-6, and there is more than a superficial
resemblance between caseation and atheroma, a hallmark of non-
infective atherosclerosis. Recent studies have drawn attention
to cholesterol (Huang et al., 2018) and oxysterol metabolism
(Lu et al., 2017) in immune cells and of phenolic glycolipids
in experimental mycobacterial infection (Cambier et al., 2017).
Huang et al. have stressed the capacity of MTB to access
and degrade fatty acids and sterols in order to survive within
macrophages. To gain a better understanding of prolonged host-
pathogen interactions in chronic TB, it will be necessary to
perform lipidomic analysis of the heterogeneous macrophage
populations as well as MTB, ideally, in vivo, and at the single cell
level.
CONCLUSIONS
Tuberculosis has been well documented as a clinical and
pathological entity, yet many aspects of the disease remain
unclear; while its rich natural history provides unique
opportunities for fundamental and applied research. Since
the nineteenth century it has been known that macrophages
are an integral component of its pathogenesis and sequelae. In
this review we have shown how cellular and molecular advances
have generated new insights into the role of macrophages and,
conversely how tuberculosis research continues to provide
a wealth of theoretical and practical problems for study of
macrophage immunobiology. Although we are beginning to
understand the phenotypic distinction between tissue- resident
yolk sac-derived and inflammatory bone marrow- derived
macrophages in the mouse, this concept needs validation in
humans; moreover, we do not know the impact of specific organ
localization as well as origin on macrophage- MTB interactions.
The extensive heterogeneity of macrophage populations in
vivo, revealed by population and single cell analysis, mandates
exquisite selectivity to target particular subsets of infected
cells, without collateral injury to the host, as emphasized by
Srivastava et al. (2014). Furthermore, the associated caseation
and fibrosis, hallmark complications of the human disease,
are poorly expressed in experimental models and in vitro;
distinctions between the immune response to TB in humans
and in animal models are emphasized by Scriba et al. (2017).
Further progress will depend on access to human tissue from
patients, the development of sensitive methods to study small
amounts of tissue in situ, ideally by non-invasive methods over
the course of the disease, and validation with in vitro models of
human cells as well as development of new animal models that
mimic the disease in humans. Shorter courses and more effective
drug treatment of patients will be achieved by high throughput
screening within macrophages to identify novel mycobacterial
targets. The role of macrophages in granuloma and giant cell
formation, epitheliodisation, caseation and fibrosis, all associated
with TB, requires further investigation.
Study of tuberculous granulomas should promote
understanding of other granulomatous diseases such as
sarcoidosis and autoimmune destructive conditions such as
Granulomatosis with polyangiitis, formerly called Wegener’s
granulomatosis. The co-epidemic of TB with HIV-1/AIDS,
characteristically treated as a T cell failure, also involves
macrophage dysfunction, as a viral reservoir, but especially
when successful HAART restores CD4T lymphocyte function,
resulting in the Immune reconstitution inflammatory syndrome
(IRIS) (Bell et al., 2017). Corticosteroid treatment, usually
associated with increased risk in TB treatment, may be of benefit
in preventing this outcome.
Apart from its remaining, but limited value as a vaccine, BCG
offers a useful starting point to probe macrophage functions
as an immunological adjuvant, in non-tuberculous intracellular
infections and in selected cancer therapy. Recent benefits
from BCG administration have been ascribed to imprinting
haematopoietic stem cells in bone marrow to generate daughter
macrophages with enhanced antimycobacterial effector function
(Kaufmann et al., 2018). Dissection of the BCG genome should
reveal new immunomodulatory prospects, without side effects
resulting from unbridled macrophage activation. Perhaps most
exciting will be to utilize such information in host-directed
and combination therapy of drug-resistant Tuberculosis (Reiche
et al., 2017), for example, targeting DNA replication and repair
for the development of novel therapeutics against TB (Guler and
Brombacher, 2015).
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